1Reimann-Hunziker G. Uber experimentelle Thromboseund ihre Behandlung mit Heparin[J]. Schweiz Med Wochenschr, 1944,74 (1) :66-69.
2Kurz K D, Main B W, Sandusky G E. Rat model of arterial thrombosis induced by ferric chloride[J]. Thromb Res, 1990,60 (4) :269-280.
3Wang X, Xu L. An optimized murine model of ferric chlorideinduced arterial thrombosis for thrombosis research[J]. Thromb Res,2005,115(1-2) :95-100.
4Dogne J M, Rolin S, Petein M, et al. Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig[J]. Thromb Res,2005,116(5):431-442.
5Marsh L E, Lewis S D, Lehman E D, et al. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis [J]. Thromb Haemost, 1998,79(3) :656-662.
6Elg M, Borjesson I, Carlsson S. Three vehicle formulations for melagatran, a direct thrombin inhibitor, evaluated in a vena cava thrombosis model in the rat[J]. Biopharm Drug Dispos,2003,24 (6) :251-257.
7Carlsson S, Elg M, Mattsson C, et al. Effects of ximelagatran, the oral form of melagatran, in the treatment of caval vein thrombosis in conscious rats[J]. Thromb Res, 2002,107 (3-4) :163-168.
8Carlsson S, Elg M. The effects of ximelagatran and warfarin on the prophylaxis of a caval vein thrombosis and bleeding in the anaesthetized rat[J]. Blood Coagul Fibrinolysis, 2005, 16 (4) : 245-249.
9Srivastava A K, Gupta R K, Haris M, et al. Cerebral venous sinus thrombosis: developing an experimental model [J]. Neurosei Methods,2007,161(2):220-222.
10Wang X, Smith P L, Hsu M Y, et al. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor[J]. Thromb Haemost, 2006, 4(2) :403-410.
3Blebea J,Strothman G,Fowl R.Bilateral lower-extremity US for deep venous thrombosis.Radiology,1995,197:315-316
4Unger EC,McCreery TP,Sweitzer RH,et al.In vitro studies of a new thrombus-specific ultrasound contrast agent.Am.J.Cardiol,1998,81:58G-61G
5Schumann PA,Christiansen JP,Quigley RM,et al.Targeted-micro-bubble binding selectively to GPIIb/IIIa receptors of platelet thrombi.Invest Radiol,2002,37(11):587-593
6Mousa SA,Bozarth JM,Edwards S,et al.Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.Coron Artery Dis,1998,9:131-141
7Kurz KD,Main BW,Sandusky GE,et al.Rat model of arterial thro-mbosis induced by ferric chloride.Thromb Res.1999,2:269-280
8Kurz K D,Main B W,Sandusky G E.Rat model of arterial thrombosis induced by ferric chloride[J].Thromb Res,1990,60 (4):269-80.
9Aoki T,Cox D,Senzaki K,et al.Comparison of the antithrombotic effects of FK 633,GP Ⅱ b/Ⅲ a antagonist,and aspirin in a guinea pig thrombosis model[J].Thromb Res,1998,89 (3):129-36.
10Chen L Y,Jokela R,Li D Y,et al.Effect of stable fish oil on arterial thrombogenesis,platelet aggregation,and superoxide dismutase activity[J].J Cardiovasc Pharmacol,2000,35 (3):502 -5.
